Data / Form D filings / Revalia Bio, Inc.
Revalia Bio, Inc.: Form D filing
Revalia Bio, Inc., a biotechnology company in New Haven, CT, filed a Form D with the SEC in 2024. The latest, on November 6, 2024, reports $12.3 million sold of a $17 million offering to 32 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 55 CHURCH STREET, #400, New Haven, CT, 06510
- Phone
- (312) 520-8301
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2043834
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | New notice | $16,996,251 | $12,294,616 | $4,701,635 | 32 | Oct 25, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Milad T. Alucozai | Director | |
| Brian T. Wilcove | Director | |
| Gregory T. Tietjen | Executive Officer, Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Nov 4, 2024 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Revalia Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.